• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紧跟追赶步伐:来自国家人乳头瘤病毒疫苗接种计划登记处的澳大利亚18至26岁女性的人乳头瘤病毒疫苗接种覆盖率数据。

Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register.

作者信息

Brotherton Julia, Gertig Dorota, Chappell Genevieve, Rowlands Lesley, Saville Marion

机构信息

National HPV Vaccination Program Register, East Melbourne, Victoria.

出版信息

Commun Dis Intell Q Rep. 2011 Jun;35(2):197-201.

PMID:22010515
Abstract

This report describes human papillomavirus (HPV) vaccine coverage data for Australian women 18-26 years of age, as notified to the National Human Papillomavirus Vaccination Program Register. A cross-sectional analysis was conducted of notifications to the Register of HPV vaccine doses delivered as part of the National HPV Vaccination Program, which provided free catch-up vaccination to women 18-26 years of age across Australia between 2007 and 2009. HPV vaccination coverage estimates were calculated by age, state or territory of residence and dose number, using the Australian Bureau of Statistics population estimates as the denominator. As at March 2011, approximately 4.49 million doses had been notified to the Register of females of all ages, and 1.7 million of these were for women aged 18-26 years in 2007. Vaccination coverage was highest for females aged 18 years and lowest in females aged 26 years. For the entire 18-26 years cohort, coverage was estimated at 55.2% for dose 1, 44.8% for dose 2 and 31.7% for dose 3. Notified dose 1 coverage rates by single year of age and state or territory ranged between 22% for females aged 26 years in the Northern Territory and 76% in females aged 18 years in Queensland, with dose 1 coverage highest across the age range in the Northern Territory, Queensland and South Australia. These data suggest that over half of Australian women aged 18-26 years commenced HPV vaccine courses and about one-third are fully vaccinated. Some of the differences in the coverage observed between states and territories likely reflect differing mechanisms for notifying to the Register.

摘要

本报告描述了澳大利亚18至26岁女性的人乳头瘤病毒(HPV)疫苗接种覆盖率数据,这些数据已通报至国家人乳头瘤病毒疫苗接种计划登记处。对作为国家HPV疫苗接种计划一部分而接种的HPV疫苗剂量通报情况进行了横断面分析,该计划在2007年至2009年期间为澳大利亚各地18至26岁的女性提供免费补种疫苗。HPV疫苗接种覆盖率估计数按年龄、居住州或领地以及接种剂量计算,使用澳大利亚统计局的人口估计数作为分母。截至2011年3月,所有年龄段女性的约449万剂疫苗接种情况已通报至登记处,其中170万剂是2007年18至26岁女性的接种情况。18岁女性的疫苗接种覆盖率最高,26岁女性的覆盖率最低。对于整个18至26岁年龄组,第1剂疫苗的覆盖率估计为55.2%,第2剂为44.8%,第3剂为31.7%。按单一年龄和州或领地划分的第1剂疫苗通报覆盖率在北领地26岁女性的22%至昆士兰州18岁女性的76%之间,北领地、昆士兰州和南澳大利亚州在各年龄组中的第1剂疫苗覆盖率最高。这些数据表明,超过一半的澳大利亚18至26岁女性开始接种HPV疫苗课程,约三分之一已完成全程接种。各州和领地之间观察到的覆盖率差异可能部分反映了向登记处通报情况的不同机制。

相似文献

1
Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register.紧跟追赶步伐:来自国家人乳头瘤病毒疫苗接种计划登记处的澳大利亚18至26岁女性的人乳头瘤病毒疫苗接种覆盖率数据。
Commun Dis Intell Q Rep. 2011 Jun;35(2):197-201.
2
Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey.澳大利亚年轻女性的人乳头瘤病毒 (HPV) 疫苗接种率高于此前估计:一项全国代表性手机调查的独立估计。
Vaccine. 2014 Jan 23;32(5):592-7. doi: 10.1016/j.vaccine.2013.11.075. Epub 2013 Dec 5.
3
Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach.澳大利亚少女人群中人类乳头瘤病毒疫苗接种率:基于学校的方法的成功。
Med J Aust. 2013 Nov 4;199(9):614-7. doi: 10.5694/mja13.10272.
4
HPV vaccination coverage: slightly improved two-dose schedule completion estimates and historical estimates lower on AIR than HPV Register.HPV 疫苗接种覆盖率:两剂次接种程序完成率略有提高,而与 HPV 登记系统相比,接种率的历史估计值较低。
Aust N Z J Public Health. 2022 Jun;46(3):394-400. doi: 10.1111/1753-6405.13233. Epub 2022 Mar 31.
5
HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015.HPV 疫苗接种覆盖率和完成率在澳大利亚原住民青少年中,2015 年。
Med J Aust. 2019 Jul;211(1):31-36. doi: 10.5694/mja2.50221. Epub 2019 Jun 9.
6
Immunisation coverage, 2012.2012年免疫接种覆盖率
Commun Dis Intell Q Rep. 2014 Sep 30;38(3):E208-31.
7
Annual Immunisation Coverage Report 2017.《2017年年度免疫接种覆盖率报告》
Commun Dis Intell (2018). 2019 Nov 18;43. doi: 10.33321/cdi.2019.43.47.
8
Measuring HPV vaccination coverage in Australia: comparing two alternative population-based denominators.衡量澳大利亚人乳头瘤病毒疫苗接种覆盖率:比较两种基于人群的替代分母。
Aust N Z J Public Health. 2015 Aug;39(4):326-30. doi: 10.1111/1753-6405.12372. Epub 2015 Jun 11.
9
Estimating human papillomavirus vaccination coverage among young women in Victoria and reasons for non-vaccination.评估维多利亚州年轻女性的人乳头瘤病毒疫苗接种覆盖率及未接种疫苗的原因。
Sex Health. 2016 Apr;13(2):190-2. doi: 10.1071/SH15131.
10
Adolescent and young adult HPV vaccination in Australia: achievements and challenges.澳大利亚青少年和青年 HPV 疫苗接种:成就与挑战。
Prev Med. 2011 Oct;53 Suppl 1:S29-35. doi: 10.1016/j.ypmed.2011.08.015.

引用本文的文献

1
Sustained Decline in Hospitalisations for Anogenital Warts in Australia: Analysis of National Hospital Morbidity Data 2003-2020.澳大利亚肛门生殖器疣住院人数持续下降:2003 - 2020年全国医院发病率数据分析
Trop Med Infect Dis. 2024 Apr 8;9(4):79. doi: 10.3390/tropicalmed9040079.
2
Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective.人乳头瘤病毒疫苗在中低收入国家的接种:进展、障碍和未来展望。
Front Immunol. 2023 May 12;14:1150238. doi: 10.3389/fimmu.2023.1150238. eCollection 2023.
3
Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
澳大利亚新南威尔士州 1994-2013 年与妊娠相关的妇科癌症:基于人群的历史队列研究。
Acta Obstet Gynecol Scand. 2024 Apr;103(4):729-739. doi: 10.1111/aogs.14530. Epub 2023 Mar 13.
4
Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence.追赶式人乳头瘤病毒疫苗接种对肯尼亚宫颈癌发病率的影响:在中度艾滋病毒流行背景下对人乳头瘤病毒疫苗接种策略的数学建模评估
EClinicalMedicine. 2022 Feb 19;45:101306. doi: 10.1016/j.eclinm.2022.101306. eCollection 2022 Mar.
5
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.2017年至2035年人乳头瘤病毒(HPV)疫苗接种和原发性HPV筛查对宫颈癌发病率的未来预测影响:以澳大利亚为例
PLoS One. 2018 Feb 14;13(2):e0185332. doi: 10.1371/journal.pone.0185332. eCollection 2018.
6
Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.指南针研究方案:一项针对澳大利亚25至69岁未接种和已接种HPV疫苗女性的宫颈癌初级HPV检测与细胞学筛查的随机对照试验。
BMJ Open. 2018 Jan 26;8(1):e016700. doi: 10.1136/bmjopen-2017-016700.
7
Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use.从基于细胞学的筛查过渡到更长间隔的基于人乳头瘤病毒(HPV)的筛查:对资源利用的影响
BMC Health Serv Res. 2016 Apr 26;16:147. doi: 10.1186/s12913-016-1375-9.
8
Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.澳大利亚30岁以上细胞学正常及高级别宫颈异常的未接种疫苗女性中16/18型人乳头瘤病毒血清流行率:一项观察性研究的结果
BMC Infect Dis. 2014 Dec 21;14:3861. doi: 10.1186/s12879-014-0676-z.
9
Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study.通过一项由公共资金支持的、基于学校的项目有效接种人乳头瘤病毒(HPV)疫苗的证据:安大略省八年级HPV疫苗队列研究。
BMC Public Health. 2014 Oct 3;14:1029. doi: 10.1186/1471-2458-14-1029.
10
Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.根据人乳头瘤病毒疫苗接种计划结果的新数据检验先前模型的预测。
BMC Res Notes. 2014 Feb 25;7:109. doi: 10.1186/1756-0500-7-109.